Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 14;145(24):1780-1783.
doi: 10.1161/CIRCULATIONAHA.122.059935. Epub 2022 Jun 13.

At the Crossroad Between Skeletal and Cardiac Muscle Cells

Affiliations
Editorial

At the Crossroad Between Skeletal and Cardiac Muscle Cells

Christopher R deFilippi et al. Circulation. .
No abstract available

Keywords: Editorials; biomarkers; muscle, skeletal; myocardium; troponin.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Adults with pre-frailty, frailty or others with co-morbidities may have skeletal muscle loss or disorders that could result in cTnT production (left panel). Circulating cTnT, but not cTnI is measurable by high sensitivity assays in patients without known cardiovascular disease, but skeletal myopathy or myositis (from du Fay de Lavallaz et al.) (middle panel). Prior longitudinal ambulatory studies show that both cTnI and cTnT levels are long-term prognosticators for incident heart failure, but hs-cTnI is more prognostic of incident MI (right panel). cTnI, cardiac troponin I; cTnT, cardiac troponin T; hs, high sensitivity; ULN, upper limit of normal (defined as the 99th percentile value in a healthy adult population).

Comment on

  • Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.
    du Fay de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, Wanschitz J, Löscher WN, Schreiner B, Katan M, Jung HH, Maurer B, Hammerer-Lercher A, Mayr A, Gualandro DM, Acket A, Puelacher C, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, Glarner N, Shrestha S, Manka R, Gawinecka J, Piscuoglio S, Gallon J, Wiedemann S, Sinnreich M, Mueller C; BASEL XII Investigators. du Fay de Lavallaz J, et al. Circulation. 2022 Jun 14;145(24):1764-1779. doi: 10.1161/CIRCULATIONAHA.121.058489. Epub 2022 Apr 7. Circulation. 2022. PMID: 35389756 Free PMC article.

References

    1. Keele KD. Leonardo da Vinci as physiologist. Postgrad Med J. 1952;28:521–8. - PMC - PubMed
    1. du Fay de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, Wanschitz J, Löscher WN, Schreiner B, et al. Skeletal Muscle Disorders: A Non-cardiac Source of Cardiac Troponin T. Circulation. 2022. - PMC - PubMed
    1. Rittoo D, Jones A, Lecky B and Neithercut D. Elevation of Cardiac Troponin T, But Not Cardiac Troponin I, in Patients With Neuromuscular Diseases: Implications for the Diagnosis of Myocardial Infarction. Journal of the American College of Cardiology. 2014;63:2411–2420. - PubMed
    1. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN and Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011;58:1819–24. - PubMed
    1. Ijaz N, Buta B, Xue QL, Mohess DT, Bushan A, Tran H, Batchelor W, deFilippi CR, Walston JD, Bandeen-Roche K, et al. Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79:482–503. - PMC - PubMed